Calumet, Inc. /DE

For the period ended Mar 31, 2025. Filed May 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

CLMT$34.91-3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Condensed Consolidated Statements of Operations


	Three Months Ended March 31,
· 2025 · 2024
· · · · · ·
· · · · · ·
Sales		$993.9	$1,005.8
Cost of sales		1,075.3	927.3
Gross profit (loss)		(81.4)	78.5
Operating costs and expenses:
Selling		12.3	13.7
General and administrative		12.1	23.3
Gain on sale of business		(62.2)	—
Other operating expense		5.1	5.2
Operating income (loss)		(48.7)	36.3

Other income (expense):
Interest expense		(58.5)	(60.8)
Debt extinguishment costs		(47.6)	(0.2)
Loss on derivative instruments		(7.2)	(16.9)
Other income		0.4	0.2
Total other expense		(112.9)	(77.7)
Net loss before income taxes		(161.6)	(41.4)
Income tax expense		0.4	0.2
Net loss		$(162.0)	$(41.6)
Allocation of net loss to partners:
Net loss attributable to partners			(41.6)
Less:
General partners' interest in net loss			(0.8)
Net loss available to limited partners			$(40.8)
Earnings per share / Limited partners' interest net loss per unit:
Basic and diluted		$(1.87)	$(0.51)
Weighted average number of common shares outstanding / limited partner units outstanding:
Basic and diluted		86,428,634	80,352,403

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.